Skip to main content
Fig. 1 | Journal of Pharmaceutical Policy and Practice

Fig. 1

From: Access to innovative cancer medicines in a middle-income country - the case of Mexico

Fig. 1

Mexico – the five regions of study. Region 1 (North): Baja California, Baja California Sur, Chihuahua, Coahuila, Durango, Nuevo León, Sinaloa, Sonora, Tamaulipas. Region 2 (Center): Mexico City, Mexico State, Guanajuato, Morelos, Querétaro, San Luis Potosí, Zacatecas. Region 3 (West): Aguascalientes, Colima, Guerrero, Jalisco, Michoacan, Nayarit. Region 4 (East): Hidalgo, Puebla, Tlaxcala, Veracruz. Region 5 (South): Campeche, Chiapas, Oaxaca, Quintana Roo, Tabasco, Yucatan.

Back to article page